Daclizumab in anaplastic large cell lymphoma [2]

Leukemia and Lymphoma

Volumn 47, Issue 1, 2006, Pages 175-

  Grigg, Andrew ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DACLIZUMAB; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; VINCRISTINE;

ABDOMINAL DISEASE; ADULT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER STAGING; CASE REPORT; CRANIAL NERVE PARALYSIS; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HUMAN; LARGE CELL LYMPHOMA; LETTER; LYMPH NODE BIOPSY; LYMPHADENOPATHY; PANCYTOPENIA; PRIORITY JOURNAL; SKIN NODULE; WHOLE BODY RADIATION;

ADULT; ANTIBODIES, MONOCLONAL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN G; LYMPHOMA, LARGE-CELL, KI-1; RECURRENCE; TREATMENT FAILURE;

EID: 30844457268     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500286150     Document Type: Letter

References (4)

1. Linden, O. (2004) Remission of a refractory, anaplastic large-cell lymphoma after treatment with daclizumab New England Journal of Medicine, 351, pp. 1466 - 1467.
2. Koller, C and Kantarjian, H and Thomas, D and O'Brien, S and Rios, M and Kornblau, S et al. (1997) The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia Leukemia, 11, pp. 2039 - 2044.
3. Seidemann, K and Tiemann, M and Schrappe, M and Yakisan, E and Simonitsch, I and Janka-Schaub, G and (2001) Short-pulse B-non Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM90 Blood, 97, pp. 3699 - 3706.
4. Janik, J and Morris, J and Pittaluga, S and McDonald, K and Raffeld, M and Jaffe, E and (2004) Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma Blood, 104, pp. 3355 - 3357.